Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Cenani-Lenz Syndactyly Syndrome is a rare congenital disorder characterized by complete or partial fusion of fingers and/or toes (syndactyly). This genetic condition is typically diagnosed through clinical examination and confirmed by genetic testing. While there is no single blood test to diagnose this syndrome directly, laboratory testing can play a supporting role in the evaluation process.
This panel tests for antibodies against LRP4 protein, which is directly related to the genetic cause of Cenani-Lenz Syndactyly Syndrome. While the presence of LRP4 antibodies may not directly indicate this disorder, abnormal LRP4 function detected through this testing may provide valuable information that leads healthcare providers to pursue further genetic testing for definitive diagnosis.
Cenani-Lenz Syndactyly Syndrome is caused by mutations in the LRP4 gene, which affects protein function involved in limb development. Blood testing is fundamental for assessing related protein functions and antibody responses that may guide healthcare providers toward more comprehensive genetic evaluation when the clinical presentation suggests this rare condition.
The LRP4 gene mutations responsible for Cenani-Lenz Syndactyly Syndrome affect normal limb development during embryonic growth. Testing for LRP4-related antibodies can help healthcare providers understand protein function abnormalities that may be associated with the underlying genetic changes, though genetic testing remains the gold standard for confirming the diagnosis.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.